Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine

BACKGROUND: Marburg virus (MARV) is the causative agent of Marburg virus disease (MVD) which has a case fatality rate up to ∼90% in humans. Recently, there were cases reported in Guinea and Ghana highlighting this virus as a high-consequence pathogen potentially threatening global public health. The...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Donnell, Kyle L., Feldmann, Friederike, Kaza, Benjamin, Clancy, Chad S., Hanley, Patrick W., Fletcher, Paige, Marzi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947254/
https://www.ncbi.nlm.nih.gov/pubmed/36774693
http://dx.doi.org/10.1016/j.ebiom.2023.104463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947254/
https://www.ncbi.nlm.nih.gov/pubmed/36774693
http://dx.doi.org/10.1016/j.ebiom.2023.104463

Ejemplares similares